| Product Code: ETC7740413 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a low concentration with a Herfindahl-Hirschman Index (HHI), Japan's import shipments of insulin drugs and devices in 2024 saw a decline in both the compound annual growth rate (CAGR) and the growth rate from 2023 to 2024. The top exporting countries to Japan in this sector were Germany, Switzerland, USA, Italy, and Metropolitan France. This data suggests a challenging market environment with decreasing import volumes, highlighting potential shifts in consumer demand or competitive dynamics within the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Insulin Drugs & Devices Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Insulin Drugs & Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 Japan Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 Japan Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2021 & 2031F |
3.6 Japan Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2021 & 2031F |
3.7 Japan Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2021 & 2031F |
3.8 Japan Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2021 & 2031F |
4 Japan Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Japan |
4.2.2 Technological advancements in insulin drugs and devices |
4.2.3 Rising awareness about diabetes management and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of insulin drugs and devices |
4.3.2 High cost associated with insulin therapy |
4.3.3 Limited access to healthcare services in rural areas |
5 Japan Insulin Drugs & Devices Market Trends |
6 Japan Insulin Drugs & Devices Market, By Types |
6.1 Japan Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 Japan Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2021- 2031F |
6.1.3 Japan Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2021- 2031F |
6.1.4 Japan Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2021- 2031F |
6.1.5 Japan Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2021- 2031F |
6.1.6 Japan Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2021- 2031F |
6.2 Japan Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 Japan Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2021- 2031F |
6.2.3 Japan Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2021- 2031F |
6.3 Japan Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 Japan Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2021- 2031F |
6.3.3 Japan Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2021- 2031F |
6.4 Japan Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 Japan Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2021- 2031F |
6.4.3 Japan Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2021- 2031F |
6.4.4 Japan Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2021- 2031F |
6.4.5 Japan Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2021- 2031F |
7 Japan Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 Japan Insulin Drugs & Devices Market Export to Major Countries |
7.2 Japan Insulin Drugs & Devices Market Imports from Major Countries |
8 Japan Insulin Drugs & Devices Market Key Performance Indicators |
8.1 Adoption rate of new insulin drugs and devices in the market |
8.2 Patient satisfaction and adherence rates with insulin therapy |
8.3 Number of diabetes education programs and initiatives implemented |
9 Japan Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 Japan Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2021 & 2031F |
9.2 Japan Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2021 & 2031F |
9.3 Japan Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2021 & 2031F |
9.4 Japan Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2021 & 2031F |
10 Japan Insulin Drugs & Devices Market - Competitive Landscape |
10.1 Japan Insulin Drugs & Devices Market Revenue Share, By Companies, 2024 |
10.2 Japan Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here